CollPlant Biotechnologies Ltd (CLGN)
Last updated: 2026-10-22 19:33:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
CollPlant Biotechnologies Ltd (CLGN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $3.64, with a market capitalization of $7.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.64 to $26.00. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$7.34M | |
$3.71 | |
$242.60 | |
$2.64 | |
$3.76 | |
10.34K | |
367.62K | |
-- | |
$26.00 | |
$2.64 | |
-- | |
-- |
CollPlant Biotechnologies Ltd (CLGN) Stock Price Today
CollPlant Biotechnologies Ltd (CLGN) is currently trading at $3.64 as of 2026-10-22 19:26:00, down 3.20% ($0.12) from the previous close of $3.76
During today's regular trading session, CLGN has traded between $2.64 and $242.60, with a trading volume of 10.34K shares. The current price is near the lower end of today's range.
CollPlant Biotechnologies Ltd (CLGN) 7-Day Stock Price Change
Over the past seven days, CollPlant Biotechnologies Ltd (CLGN) moved from $3.91 to $3.64, representing a decline of 7.03% ($0.28).
The stock traded between $3.40 and $4.13 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 33.23 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CLGN 52-Week Price Position
Position in Range: 4.3%
CLGN is currently trading at $3.64, placing it 4.3% of the way from its 52-week low of $2.64 to its 52-week high of $26.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is CollPlant Biotechnologies Ltd (CLGN)?
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.
CollPlant Biotechnologies Ltd Information
| Employees | 39 |
| Exchange | NASDAQ |
| Company Website |
How to Buy CollPlant Biotechnologies Ltd (CLGN) Stock on MEXC
Eligible investors can buy real shares of CollPlant Biotechnologies Ltd (CLGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is CollPlant Biotechnologies Ltd (CLGN) stock price today?
2.Is CLGN stock going up or down today?
3.What is CLGN pre-market price?
4.What is CLGN after-hours price?
5.Is CLGN stock trading now?
6.Where does CLGN sit relative to its 52-week high and low?
7.What sector is CollPlant Biotechnologies Ltd in?
8.What is CollPlant Biotechnologies Ltd's market capitalization and where is it listed?
9.How is CLGN valued in terms of P/E ratio and EPS?
10.Does CollPlant Biotechnologies Ltd pay a dividend?
Explore More US Stocks
Search Stocks
CLGN Stock Calculator
Estimate the value between CLGN shares and USD.
CLGN Shares to USD
1.00 CLGN shares = 3.635 USD
Calculations are estimates based on the latest available price and are for reference only.


